FDA Approves Drug for Intravenous Use in Lactating Diary Cows

FluNix-D can reduce BRD and edotoxemia symptoms; approved for intravenous, not intramuscular use.

The U.S. Food and Drug Administration has approved the use of FluNix-D in lactating dairy cows. The drug, produced by AgriLabs, is a Non-Steroidal Anti-Inflammatory Drug designed to provide safe therapy for dairy cows by reducing the fever and inflammation caused by Bovine Respiratory Disease and endotoxemia.

The AgriLabs announcement of the drug's approval erroneously said that FluNix-D can be administered intravenously or intramuscularly, but should have only stated that intravenous use has been approved. The FDA has not approved FluNix-D for intramuscular administration in lactating dairy cows.

The drug has a 36-hour milk withdrawal and four-day meat withdrawal in lactating dairy cows. Flunixin Meglumine had earlier been cleared for use in beef cattle and non-lactating dairy cows. It was only recently approved for use in lactating dairy cows.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.